•  
  •  
 

Central Asian Journal of Medicine

Abstract

Hepatitis Delta is severe and rapidly progressing form of viral hepatitis which leading to the liver cirrhosis and this infection is still an unresolved global health problem. The treatment of delta-virus infection is an unresolved problem. The application of the interferon preparations in case of delta-infection does not guarantee the efficacy of the treatment in the majority of patients, does not provide the stability of the elimination of the virus and gives a set of side-effects. New preparations with other mechanisms of the actions are now developing. These are nucleosides analogues and preparations with the specific mechanisms of action like Myrcludex B, Lonafarnib, REP 2139 which are in process of clinical tests. The combined therapy by the interferons and the nucleoside analogues seems to be perspective.

First Page

17

Last Page

29

References

1. Abdurahmanov D.T., Hronicheskiy gepatit B i D (Chronic hepatitis B and D), M., GEOTAR Media, 2010; 288 p. 2. Abdurakhmanov D.T., Krel P.E., Lopatkina T.N., et al. Chronic hepatitis D: clinical characteristics, course and prognosis. Clinical hepatology, 2009; 1:47—50. 3. Alfaiate D., Dény P., Durantel D. Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options. (англ.) // Antiviral research. - 2015. - Vol. 122. - P. 112-129. DOI:10.1016/j.antiviral.2015.08.009. - PMID 26275800 4. B.Pinarbasi Simsek, D.Onel, M.Gulluoglu, F.Akyuz, H.Issever, S.Badur, K.Demir, F. Besisik, S.Ozdil, G.Boztas, Z.Mungan and S.Kaymakoglu. Correlation of Hepatitis B Virus Surface Antigen Titer with Hepatitis Delta Virus Replication Level and Histological Activity in Chronic Hepatitis D. Biomed J Sci. Tech Res. Volume 2 - Issue 1. 5. Botelho-Souza LF, Souza Vieira D, de Oliveira Dos Santos A, Cunha Pereira AV, Villalobos-Salcedo JM. Characterization of the genotypic profile of Hepatitis Delta virus: isolation of HDV Genotype-1 in the western Amazon region of Brazil. Intervirology. [Internet]. 2015; 58:166–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26112316. Cited 6 July 2016. 6. Braga WSM. Hepatitis B and D virus infection within Amerindians ethnic groups in the Brazilian Amazon: epidemiological aspects. Rev Soc Bras MedTrop. [Internet]. 2004; 37 (Suppl 2): 9–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15586891. Cited 6 July 2016. 7. Casey J.L, Brown T.L, Colan E.J, Wignall F.S, Gerin J.L. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci USA. [Internet]. 1993; 90: 9016–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8415646. Cited 6 July 2016. 8. Chen P.J., Kalpana G., Goldberg J., et al. (1986). Structure and replication of the genome of the hepatitis delta virus, Proc NatI AcadSci USA 83:8774-8. 9. Chen W, Liu J, Gluud C. 2003. Bile acids for viral hepatitis. Cochrane Database Syst. Rev. 2003(2):CD003181. http://dx.doi.org/10.1002/14651858 .CD003181. 10. Daminov T.A., Kamilov A.I, Tuychiev L.N, Hegay T.R., Clinical and epidemiological aspects of hepatitis B virus genotypes found in Uzbekistan. The Journal "Voprosi sovremennoy pediatrii" 2003, t.2, №3, p. 98-100. 11. Dény P. Hepatitis delta virus genetic variability: from genotypes I, II, III to eight major clades? Curr Top Microbiol Immunol. [Internet]. 2006; 307:151–71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16903225. Cited 6 July 2016. 12. Dény P., Durantel D. Hepatitis delta virus: From biological and medical aspects to current and investigational therapeutic options. // Antiviral research. - 2015. - Vol. 122. - P. 112-129. DOI:10.1016/j.antiviral.2015.08.009. - PMID 26275800. 13. Farci P. Delta hepatitis: an update. J Hepatol. [Internet]. 2003;39 (Suppl 1): S212–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14708706. Cited 6 July 2016. 14. Fields Virology / Editors-in-chief David M. Knipe, Peter M. Howley. - Sixth edition. - Philadelphia, USA: Lippincott Williams & Wilkins, 2013. - 2582 p. - ISBN 978-1-4511-0563-6. 15. Flodgren E., Bengtsson S., Knutsson M. et al. Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains. J. ClinKi Microbiol. 2000; 38: 3311—6. 16. Freitas, N.; Cunha, C.; Menne, S.; Gudima, S.O. Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles. J. Virol. 2014, 88, 5742–5754. 17. Galsky J, Bansky G, Holubova T, Konig J. 1999. Effect of ursodeoxycholic acid in acute viral hepatitis. J. Clin. Gastroenterol.28:249–253. 18. Giersch K, Homs M, Volz T, Helbig M, Allweiss L, Lohse AW, Petersen J, Buti M, Pollicino T, Buro C, Dandri M, Lütgehetmann M. Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice. Scientific Reports | 7: 3757 | DOI:10.1038/s41598-017-03946-9 19. Glenn J.S., Watson J.A., Havel C.M., White J.M. Identification of a prenylation site in delta virus large antigen. Science 1992, 256, 1331–1333. [CrossRef] [PubMed] 20. Hagenbuch B, Meier PJ. 1994. Molecular cloning, chromosomal localization, and functional characterization of a human liver Na_/bile acid cotransporter. J. Clin. Invest. 93:1326–1331. 7. 21. He W, Cao Z, Mao F, Ren B, Li Y, Li D, Li H, Peng B, Yan H, Qi Y, Sun Y, Wang F, Sui J, Li W. 2016. Modification of three amino acids in sodium taurocholate cotransporting polypeptide renders mice susceptible to infection with hepatitis D virus in vivo. JVirol 90:8866 –8874. doi:10.1128/JVI.00901-16. 22. Heidrich B., Deterding K., Tillmann H.L., Raupach R., Manns M.P., Wedemeyer H. Virological and clinical characteristics of delta hepatitis in central Europe. J. Viral Hepat. 2009, 16, 883–894. [CrossRef] [PubMed]. 23. Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet. 2011; 378:73–85. 24. Hwang, S.B.; Lai, M.M. Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen. J. Virol. 1993, 67, 7659–7662. [PubMed]. 25. Inoyatova F.I. et al. Clinical and biochemical characteristics of chronic viral mixed hepatitis in children. – Detskie infeksii. – 2006. - No.1. – pages 29-32 26. Inoyatova F.I. et al. Mental status disorders in patients with chronic hepatitis B - Detskie infeksii. – 2012. - No.4. – pages 24-28 27. Inoyatova F.I. et al. The state of antioxidant protection in patients with chronic viral mixed hepatitis. - Detskie infeksii. – 2008. - No.1. – pages 23-26 28. Inoyatova F.I. et al., Clinical and laboratory aspects of chronic hepatitis B secondary to inflammation refractory anemia in children of Uzbekistan. Detskie infeksii 2017, Volume 16, No. 3. 29. Inoyatova F.I., Akhmedova А.H. Clinical and biochemical indicators of delayed sexual development of boys with the chronic hepatitis B. - Detskie infeksii. – 2011. - Volume 16. - No.3 30. Katashiba Y, Miyamoto R, Hyo A, Shimamoto K, MurakamiN, Ogata M, Amakawa R, Inaba M, Nomura S,Fukuhara S, Ito T. Interferon-α and interleukin-12 are induced,respectively, by double-stranded DNA and single stranded RNA in human myeloid dendritic cells. Immunology 2011; 132: 165-173 [PMID: 20875078 DOI: 10.1111/j.1365-2567.2010.03350. 31. Khikmatullaeva A.S., Musabaev E.I., The role of genetic factors in the development of liver cirrhosis in viral hepatitis B/D. Epidemiology and infectious deseases. 2016; 21(4) 32. Khikmatullaeva AS, Abdukadyrova MA, Asilova MU. Clinical aspects cirrhosis of the liver virus etiology. Meditsina (Almaty) = Medicine (Almaty). 2018;10(196):39-44 (In Russ.). DOI: 10.31082/1728-452X-2018-196-10-39-44 33. Kos A, Dijkema R, Arnberg AC, et al. The hepatitis delta (delta) virus possesses a circular RNA. Nature 1986;323: 558–60. 34. Kullak-Ublick GA, Stieger B, Meier PJ. 2004. Enterohepatic bile salt transporters in normal physiology and liver disease. Gastroenterology 126:322–342. http://dx.doi.org/10.1053/j.gastro.2003.06.005. 35. Kuzin S.N., Pavlov N.N., Semyonov S.I. et al. Viral hepatitis in various population groups in the Republic of Sakha (Yakutia). Journal of Microbiology, Epidemiology and Immunobiology. 2004; 1: 18—22. 36. L. Allweiss., C. Dettmer, T.Volz, K. Giersch, A. Alexandrov, H. Wedemeyer, S. Urban, J.-H. Bockmann, M. Luetgehmann, M. Dandri. Strong intrahepatic decline of hepatitis D virus RNA and antigen after 24 weeks of treatment with Myrcludex B in combinationwith Tenofovir in chronic HBV/HDV infected patients: Interim results from a multicenter, open-label phase 2b clinical trial. Journal of Hepatology Volume 68, Supplement 1, Page 90. 37. Levitan B.N., Dedov A.V. Delta hepatitis. Astrakhan: AGMA, 2001 38. Li Y.J., Macnaughton T., Gao L., Lai M.M. RNA-templated replication of hepatitis delta virus: genomic and antigenomic RNAs associate with different nuclear bodies. // Journal of virology. - 2006. - Vol. 80, No. 13. - P. 6478-6486. DOI:10.1128/JVI.02650-05. — PMID 16775335. 39. Luo G.X., Chao M., Hsieh S.Y., Sureau C., Nishikura K., Taylor J. A specific base transition occurs on replicating hepatitis delta virus RNA. J. Virol. 1990, 64, 1021–1027. [PubMed] 40. Ma S-P, Sakugawa H, Makino Y, Tadano M, Kinjo F, Saito A. The complete genomic sequence of hepatitis delta virus genotype IIb prevalent in Okinawa, Japan. J Gen Virol. [Internet]. 2003; 84:461–4. Available from: http:// www.ncbi.nlm.nih.gov/pubmed/12560580. Cited 6 July 2016. 41. Radjef N, Gordien E, Ivaniushina V, Gault E, Anaïs P, Drugan T, et al.Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol. [Internet]. 2004; 78:2537–44. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14963156. Cited 6 July 2016. 42. Rizzetto M, Canese MG, Arico S, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977;18:997–1003. 43. Rizzetto M, Clancio A. The prenylation inhibitor, lonafarnib: A new therapeutic strategy against hepatitis delta. The Lancet, Volume15, issue 10, P1119-1120. Oct 2015 44. Rizzetto M, Hadziyannis S, Hansson BG, et al. Hepatitis delta virus infection in the world: epidemiological patterns and clinical expression. Gastroenterol Int 1992;5:18–32. 45. Semyonov S.I. Epidemiological features and clinical characteristics of the viral hepatitis B, C and Delta in the Republic of Sakha (Yakutia): Abstract. dis. ... holder of Habilitation degree in Medicine М.; 2007. 46. Shahgildyan I.V., Onishenko G.G., Khuhlovich P.A. et al. The results of the study and unresolved problems of epidemiology and prevention of parenteral viral hepatitis in Russia. Journal of Microbiology, Epidemiology and Immunobiology. 1994; 5: 26-32. 47. Shakil AO, Hadziyannis S, Hoofnagle JH, Di Bisceglie AM, Gerin JL, Casey JL. Geographic distribution and genetic variability of Hepatitis Delta virus genotype I. Virology. [Internet] Academic Press. 1997;234:160–7. Available from: http://linkinghub.elsevier.com/retrieve/pii/ S004268229798644X. Cited 6 July 2016. 48. Sureau C., Guerra, B. Lanford, R.E. Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion. J. Virol. 1993, 67, 366–372., 37. 49. Vaillant A. REP 2139: Antiviral Mechanisms and Applications in Achieving Functional Control of HBV and HDV Infection. ACS Infect. Dis. 2019, 5, 5, 675-687 Publication Date:September 10, 2018 50. Wang K.S., Choo Q.L., Weiner A.J., Ou J.h., Najarian R.C., Thayer R.M., Mullenbach G.T., Denniston K.J., Gerin J.L., Houghton V. Structure, sequence and expression of the hepatitis delta viral genome. // Nature. – 1986. – Vol. 323, no/ 6088. – P. 508 – 514. – DOI:10.1038/323508a0. – PMID 3762705. 51. Wu JC, Chiang TY, Sheen IJ. Characterization and phylogenetic analysis of anovel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. J Gen Virol. [Internet]. 1998;79 (Pt 5):1105–13. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9603325. Cited 6 July 2016. 52. Yan H, Peng B, Liu Y, Xu G, He W, Ren B, Jing Z, Sui J, Li W. Viral entry of hepatitis B and D viruses and bile salts ransportation share common molecular determinants on sodium taurocholate cotransporting polypeptide. J Virol. 2014 Mar;88(6):3273-84. doi: 10.1128/JVI.03478-13. Epub 2014 Jan 3. PubMed PMID:24390325; PubMed Central PMCID: PMC3957944. 53. Zhenfeng Zhang, Christina Filzmayer Yi Ni, Holger Sültmann, Pascal Mutz, Marie-Sophie Hiet, Florian WR Vondran, Ralf Bartenschlager, Stephan Urban. Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes. Journal of Hepatology Volume 69, Issue 1, July 2018, Pages 25-35. 54. Zuccola H.J., Rozelle J.E., Lemon S.M., Erickson B.W., Hogle J.M. Structural basis of the oligomerization of hepatitis delta antigen. // Structure (London, England: 1993). – 1998. – Vol. 6, no. 7. – P. 821 – 830. – PMID 9687364

Share

COinS